Results 341 to 350 of about 102,302 (358)

Cholangitis

Surgical Clinics of North America, 2019
Jesse K. Sulzer, Lee M. Ocuin
openaire   +1 more source

British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

Gut, 2019
Michael Huw Chapman, Gideon Hirschfield, Stephen P Pereira   +2 more
exaly  

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

Hepatology, 2013
Henk R Van Buuren, Bart van Hoek, Anna A Van Geloven   +2 more
exaly  

Primary sclerosing cholangitis – a comprehensive review

Journal of Hepatology, 2017
Tom H Karlsen, Trine Folseraas
exaly  

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

Hepatology, 2009
Keith D Lindor, Kris V Kowdley, Felicity T Enders   +2 more
exaly  

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

Hepatology, 2019
Michael Trauner, Kosh Agarwal, Andrew J Muir   +2 more
exaly  

Primary sclerosing cholangitis: overview and update

Nature Reviews Gastroenterology and Hepatology, 2010
exaly  

Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis

Gut, 2019
Lijun Liao, Kai Markus Schneider, Hanns-Ulrich Marschall   +2 more
exaly  

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

Gut, 2005
exaly  

Cholangitis

2017
Abdul Saied Calvino, N. Joseph Espat
openaire   +1 more source